There were few surprises in Ilika’s FY25A results, with most financial metrics close to our recently published forecasts. The key catalyst for the company remains commercial progress on both Stereax and Goliath, for which the company notes it is entering an exciting period. Goliath is entering a phase which should see it secure additional commercial partners to complement the technology collaboration agreement already signed with Agratas. With a strategy that leaves Ilika open to sign multiple p ....